| Nosocomial infection outbreak with Enterobacter aerogenes at a neonatal intensive care unit and its outcomes DU Işık, AY Bas, F Kulali, B Ozcan, S Unal, H Yucel, N Demirel Journal of Pediatric Infectious Diseases 14 (05), 223-227, 2019 | 1 | 2019 |
| A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic … JJ Harding, A Patnaik, V Moreno, M Stein, AM Jankowska, ... Journal of Clinical Oncology 37 (8_suppl), 12-12, 2019 | 78 | 2019 |
| Reirradiation in Patients with Locoregional Recurrence or a Second Primary Neoplasm within a Previously Irradiated Area after Salvage Surgery with Reconstruction Using Pedicled … Z Szutkowski, A Kawecki, S Starościak, M Rysz, M Pietras, A Jarząbski, ... Clinics in Oncology 3 (1), 2018 | | 2018 |
| Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene JY Park, EL Virts, A Jankowska, C Wiek, M Othman, SC Chakraborty, ... Journal of medical genetics 53 (10), 672-680, 2016 | 101 | 2016 |
| Evaluation of the usefulness of the electron Monte Carlo algorithm for planning radiotherapy with the use of electron beams S Łukomska, P Kukołowicz, A Zawadzka, M Gruda, M Giżyńska, ... Polish Journal of Medical Physics and Engineering 22 (3), 49-54, 2016 | 4 | 2016 |
| VMAT or IMRT–WHAT IS THE BETTER SOLUTION IN SPARING BONE MARROW IN WPRT FOR PATIENTS AFTER PROSTATECTOMY M Poncyljusz, PF Kukolowicz, B Czyzew, A Jankowska Radiotherapy and Oncology 119, S795-S795, 2016 | | 2016 |
| Comparison of 3D-CRT and IMRT techniques in radiotherapy for post-prostatectomy patients with a higher risk of nodal involvement M Poncyljusz, P Kukołowicz, J Chorąży, B Czyżew, A Jankowska, ... Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 1 (3), 223-227, 2016 | | 2016 |
| The potential of DNA modifications as biomarkers and therapeutic targets in oncology AM Jankowska, CL Millward, CW Caldwell Expert Review of Molecular Diagnostics 15 (10), 1325-1337, 2015 | 33 | 2015 |
| AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia EL Virts, A Jankowska, C Mackay, MF Glaas, C Wiek, SL Kelich, ... Human molecular genetics 24 (18), 5093-5108, 2015 | 75 | 2015 |
| Whole pelvic radiotherapy of patients after radical prostatectomy-comparision of dose distribution in 3D-CRT and IMRT technique M Poncyljusz, P Kukołowicz, A Zawadzka, J Chorąży, B Czyżew, ... Congress of Polish Society of Medical Physics 50th anniversary of PSMP, 2015 | | 2015 |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ... Leukemia 28 (1), 78-87, 2014 | 364 | 2014 |
| Minotaur is critical for primary piRNA biogenesis VV Vagin, Y Yu, A Jankowska, Y Luo, KA Wasik, CD Malone, E Harrison, ... Rna 19 (8), 1064-1077, 2013 | 76 | 2013 |
| Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ... Leukemia 27 (6), 1301-1309, 2013 | 166 | 2013 |
| Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis V Visconte, L Zhang, R Mahfouz, A Tabarroki, HJ Rogers, E Hasrouni, ... Leukemia Research 37, S27-S27, 2013 | | 2013 |
| Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy RZ Mahfouz, A Jankowska, Q Ebrahem, X Gu, V Visconte, A Tabarroki, ... Clinical cancer research 19 (4), 938-948, 2013 | 143 | 2013 |
| Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry RJP de Magalhães, MB Vidriales, B Paiva, C Fernandez-Gimenez, ... Haematologica 98 (1), 79, 2013 | 170 | 2013 |
| Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia SA Kar, A Jankowska, H Makishima, V Visconte, A Jerez, Y Sugimoto, ... Haematologica 98 (1), 107, 2013 | 88 | 2013 |
| Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies H Sakaguchi, H Makishima, H Muramatsu, V Visconte, A Jerez, ... Leukemia research 36 (12), e215, 2012 | 2 | 2012 |
| Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del [5q] treated with lenalidomide Y Sugimoto, MA Sekeres, H Makishima, F Traina, V Visconte, ... Journal of hematology & oncology 5, 1-10, 2012 | 25 | 2012 |
| Biological rationale for the favorable clinical outcomes of patients carrying SF3B1 mutations in myelodysplastic syndromes with ring sideroblasts V Visconte, RZ Mahfouz, A Tabarroki, HJ Rogers, B Juraj, E Hasrouni, ... Blood 120 (21), 922, 2012 | 2 | 2012 |
Fabiola TrainaUniversity of Campinas在 unicamp.br 的电子邮件经过验证
